Re: Market access to new anticancer medicines for children and adolescents with cancer in Europe.

Autor: Michalowski MB; Faculdade de Medicina, Universidade Federal Do Rio Grande Do Sul, Rua Ramiro Barcelos, 2400, Porto Alegre/RS, CEP 90035-002, Brazil; Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Porto Alegre/RS, CEP 90035-903, Brazil. Electronic address: mmichalowski@hcpa.edu.br., do Monte GG; Faculdade de Medicina, Universidade Federal Do Rio Grande Do Sul, Rua Ramiro Barcelos, 2400, Porto Alegre/RS, CEP 90035-002, Brazil., Pinhatti AV; Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Porto Alegre/RS, CEP 90035-903, Brazil., Wanderley AV; Faculdade de Medicina, Universidade Federal Do Pará, Avenida Generalíssimo Deodoro, 01, Bairro Do Umarizal, Belém/PA, CEP 66.050-160, Brazil.
Jazyk: angličtina
Zdroj: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Aug; Vol. 171, pp. 22-24. Date of Electronic Publication: 2022 Jun 11.
DOI: 10.1016/j.ejca.2022.04.029
Abstrakt: Competing Interests: Conflict of interest statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Prof Michalowski receives research funding from Servier for an investigator-initiated trial. All remaining authors have declared no conflicts of interest.
Databáze: MEDLINE
Externí odkaz: